期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

胰腺癌肝转移长期生存1例 被引量：5

原文传递
导出
摘要 患者男，47岁。因“体检发现胰尾及肝脏占位性病变2d”，于2007年5月人院。常规体检B超及CT提示：胰腺尾部、肝右前叶肿块，考虑胰腺癌伴肝转移可能。人院血常规、生化、肿瘤标志物等检查未见异常，心肺腹查体无特殊阳性体征。既往糖尿病10年，胰岛素降糖治疗，血糖控制可。人院诊断：胰尾癌伴肝转移。1周后行剖腹探查＋胰尾切除＋脾切除＋肝脏包块切除术。术后病理报告：肝右叶、胰尾低分化腺癌。
作者 李泽朝 罗诗樵
机构地区 重庆医科大学附属第一医院肝胆外科
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2014年第3期402-403,共2页 China Journal of General Surgery
关键词 胰腺肿瘤 肝肿瘤 继发性 肿瘤转移 病例报告
分类号 R657.5 [医药卫生—外科学]
  • 相关文献

参考文献8

  • 1刘凤永,王茂强,段峰,樊庆胜,宋鹏,王志军.胰腺癌肝转移的介入治疗[J].中国肿瘤临床,2012,29(6):331-335. 被引量：21
  • 2龙江,傅德良,徐近,虞先浚,金忱,倪泉兴,张延龄.胰腺癌术前介入化疗作用的探讨[J].中国实用外科杂志,2004,24(5):281-284. 被引量：9
  • 3Shrikhande SV,Kleeff J,Reiser C,et al.Pancreatic resection for M1 pancreatic ductal adenocarcinoma[J].Ann Surg Oncol,2007,14(1):118-127. 被引量：1
  • 4Yamada H,Hirano S,Tanaka E,et al.Surgical treatment of liver metastatic from pancreatic cancer[J].HPB (Oxford),2006,8(2):85-88. 被引量：1
  • 5黄韬,李波,林浩铭,魏永刚,董科.转移性肝癌116例手术疗效分析[J].中国实用外科杂志,2004,24(12):747-748. 被引量：3
  • 6Azizi A,Naguib NN,Mbalisike E,et al.Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival[J].Pancreas,2011,40(8):1271-1275. 被引量：1
  • 7De Jong MC,Farnell MB,Sclabas G,et al.Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis[J].Ann Surg,2010,252(1):142-148. 被引量：1
  • 8欧阳华强,黄建琴,刘鲁明,等.多学科综合治疗胰腺癌肝转移164例临床分析[C].2009年首届全国中西医肿瘤博士及中青年医师论坛,2011,215-216. 被引量：1

二级参考文献33

  • 1Kawaoka T,Aikata H,Takaki S,et al.Transarterial infusion che-motherapy using cisplatin-lipiodol suspension with or without em-bolization for unresectable hepatocellular carcinoma[J].Cardiovasc lntervent Radiol,2009,32(4):687-694. 被引量：1
  • 2Takayasu K,Arii S,Ikai I,et al.Prospective cohort study of transar-terial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients[J].Gastroenterology,2006,131(2):461-469. 被引量：1
  • 3Yoon HJ,Kim JH,Kim KA,et al.Transcatheter arterial chemo-lip-iodol infusion for unresectable hepatocellular carcinomain 96 high-risk patients[J].Clin Radiol,2010,65(4):271-277. 被引量：1
  • 4Morimoto K,Sakaguchi H,Tanaka T,et al.Transarterial chemo-embolization using cisplatin powder in a rabbit model of liver cancer[J].Cardiovasc Intervent Radiol,2008,31(5):981-985. 被引量：1
  • 5Itsubo M,Ishikawa T,Toda G,et al.Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product p-glycoprotein in primary liver carcinoma[J].Cancer,1994,73(2):298-303. 被引量：1
  • 6Shin SW.The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma[J].Korean J Radiol,2009,10(5):425-434. 被引量：1
  • 7Moriguchi M,Takayama T,Nakamura M,et al.Phase I/II study of a fine-powder formulation of cisplatin for transcatheter arterial che-moembolization in hepatocellular carcinoma[J].Hepatol Res,2010,40(4):369-375. 被引量：1
  • 8Kawaoka T,Aikata H,Takaki S,et al.Transarterial infusion che-motherapy using cisplatin-lipiodol suspensionwith or without em-bolization for unresectable hepatocellular carcinoma[J].Cardiovasc lntervent Radiol,2009,32(4):687-694. 被引量：1
  • 9Morimoto K,Sakaguchi H,Tanaka T,et al.Transarterial chemo-embolization using cisplatin powder in a rabbit model of liver cancer[J]. Cardiovasc Intervent Radiol,2008,31(5):981-985. 被引量：1
  • 10Marelli L,Stigliano R,Triantos C,et al.Transarterial therapy for hepatocellular carcinoma:which technique is more effective? A sys-tematic review of cohort and randomized studies[J].Cardiovasc ln-tervent Radiol,2007,30(1):6-25. 被引量：1

共引文献28

同被引文献31

  • 1Cannistr/t M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. Int 1 Sure, 2015, 6(26): 873-876. 被引量：1
  • 2Tafuto S, von Arx C, De Divitiis C, et al. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Int J Surg, 2015, 6(27): 382-385. 被引量：1
  • 3Ray K. Pancreatic cancer: Pancreatic cancer exosomes prime theliver for metastasis. Nat Rev Gastroenterol Hepatol, 2015, 12(7): 371-375. 被引量：1
  • 4Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosornes initiate pre-metastatic niche formation in the liver. Nat CellBiol, 2015, 17(6): 816-826. 被引量：1
  • 5Peixoto RD, Speers C, McGahan CE, et al. Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer. CancerMed, 2015, 4(18): 1028-1033. 被引量：1
  • 6Han Y, Ru GQ, Mou X, et al. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Med Hypotheses, 2015, 3(1): 920-923. 被引量：1
  • 7Nakayama A1, Tajima H, Kitagawa H, et al. A case report of hepatic arterial infusion chemotherapy and RFA for liver metastasis from pancreatic cancer. Gan To Kagaku Ryoho, 2014, 41(12): 2205-2207. 被引量：1
  • 8Kawamoto T, Hishima T, Kimura K, et al. Calcified liver metastases from a non-functioning pancreatic neuroendocrine tumor. Clin J Gastroenterol, 201, 7(5): 460-464. 被引量：1
  • 9Bolm L, lanssen S, Kismann L, et al. Predicting survival after irradiation of metastases from pancreatic cancer. Anticancer Res, 2015, 35(7): 4105-4108. 被引量：1
  • 10Cannistr~ M, Ruggiero M, Zullo A, et al. Metastases of pancreatic adenocarcinoma: a systematic review of literature and a new functional concept. Int J Surg, 2015, 6(26):873-876. 被引量：1

引证文献5

二级引证文献9

中国普通外科杂志
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部